CoChat

The DOI matches its Crossref record; 44 of the 47 references it cites were found in a registry or an index.

The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance

Fearon, Douglas T. · 2014 · Cancer Immunology Research

Abstract

The fibroblastic element of the tumor microenvironment has been of great interest to cancer biologists but less so to cancer immunologists. Yet, the sharing of a common mesenchymal cell type in the stroma of tumors and at sites of chronic inflammatory lesions, some of which have an autoimmune basis, has been a strong hint that this cellular component of the tumor microenvironment may have an immunologic function. Recent studies have confirmed this possibility. These fibroblast-like cells, which are termed carcinoma-associated fibroblasts (CAF), can be identified by their expression of the membrane protein, fibroblast activation protein-α (FAP). The conditional depletion of the FAP+ CAF permits immune control not only of an artificial, transplanted tumor, but also of an autochthonous model of pancreatic ductal adenocarcinoma (PDA) that replicates the molecular, histologic, clinical, and immunologic characteristics of the human disease. Immune suppression by the FAP+ CAF is mediated by CXCL12, the chemokine that binds to cancer cells and excludes T cells by a mechanism that depends on signaling by the CXCL12 receptor CXCR4. Inhibition of CXCR4 leads to the elimination of cancer cells by enabling the rapid, intratumoral accumulation of preexisting, PDA-specific CD8+ T cells, and reveals the antitumor efficacy of the T-cell checkpoint antagonist anti–PD-L1. Recent studies have also shown that the FAP+ CAF is related to FAP-expressing stromal cells of normal tissues, demonstrating that cancers recruit a member of an essential stromal cell lineage that is involved not only in wound repair but also in normal tissue homeostasis. These findings extend the concept introduced by cancer biologists that the fibroblastic component of tumors has a critical role in the adaptation of the cancer to the host. Cancer Immunol Res; 2(3); 187–93. ©2014 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-14-0002

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Cited by

See all 289

Metadata

Authors
Fearon, D. T.
Affiliations
University of Cambridge (GB)
Corresponding author
Fearon, Douglas T.
Venue
Cancer Immunology Research
Published
2014-03-01
Volume
2
Issue
3
Pages
187-193
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2144325011
Cited by
288
References
47
Citations by year
2026: 13 · 2025: 22 · 2024: 34 · 2023: 30 · 2022: 38 · 2021: 30 · 2020: 27 · 2019: 22 · 2018: 23 · 2017: 17 · 2016: 17 · 2015: 12 · 2014: 3
FWCI
7.87
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Immunology Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cancer Research UK (22310)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
cancer-associated fibroblasts, fibroblast activation protein, tumor microenvironment, immune evasion, CXCL12, CXCR4, pancreatic ductal adenocarcinoma, CD8+ T cells, PD-L1 inhibitors, tumor stroma, chronic inflammation, autoimmunity, T cell checkpoint
MeSH terms
Fibroblast Activation Protein Alpha, Animals, Fibroblasts, Humans, Membrane Proteins, Neoplasms, Experimental, Pancreatic Neoplasms, Endopeptidases, Serine Endopeptidases, Stromal Cells, Gelatinases, CD8-Positive T-Lymphocytes, Drug Resistance, Neoplasm, Tumor Escape, Receptors, CXCR4, Carcinoma, Pancreatic Ductal, Mice, Chemokine CXCL12, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance. https://app.cochat.ai/papers/10.1158/2326-6066.cir-14-0002
The paper
Fearon, D. T. (2014). The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-14-0002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.